在类风湿性关节炎中预测间歇性肺病的患者级因素:系统性审查
Eric L Matteson1, Marco Matucci-Cerinic2,3, Michael Kreuter4
1Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA matteson.eric@mayo.edu.
RMD open
|July 28, 2023
概括
识别风湿性关节炎患者具有高风险的间歇性肺病 (RA-ILD) 是至关重要的. 年龄,性别,吸烟和自身抗体一致预测RA患者的ILD发展.
科学领域:
- 风湿病学和肺病学 风湿病学和肺病学
- 研究自身免疫性疾病和呼吸道并发症的交叉点.
背景情况:
- 间歇性肺病 (ILD) 是类风湿性关节炎 (RA) 患者死亡的重要原因.
- 识别患者层面的因素可以预测具有高ILD风险的RA患者,从而实现有针对性的查.
- 现有的研究往往排除了关键因素,如MUC5B遗传和甲状腺使用.
结论:
- 本综述为潜在的风险算法提供了基础的患者水平因素,用于识别用于ILD查的RA患者.
- 这些发现支持未来的研究,以提高对RA-ILD进展和患者护理的理解.
- 早期识别和管理处于风险的RA患者可以改善这种严重并发症的结果.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
83
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
83
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K


